Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Goossens

Showing results (451-460 of 485) with videos related to

Pageof 49
Sort By:
BJGP Open|December 18, 2021
Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countriesAlike W van der Velden, Alma C van de Pol, Emily Bongard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial dataTheo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Blood|August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemiaSébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2024
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)María Paniagua-García, Jose M Bravo-Ferrer, Salvador Pérez-Galera, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countriesXiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open|July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocolEmily Bongard, Alike W van der Velden, Johanna Cook, et al.
Eclinicalmedicine|March 10, 2023
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, et al.
CMAJ Open|December 22, 2021
The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional surveyGreg J German, Charles Frenette, Jean-Alexandre Caissy, et al.
Frontiers in Immunology|January 9, 2023
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsAngelina Konnova, Fien H R De Winter, Akshita Gupta, et al.
Pageof 49

Showing results (451-460 of 485) with videos related to

Sort By:
Pageof 49
BJGP Open|December 18, 2021
Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countriesAlike W van der Velden, Alma C van de Pol, Emily Bongard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial dataTheo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The Lancet. Infectious Diseases|April 24, 2021
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Hasan S Jafri, Jean Chastre, et al.
Blood|August 24, 2017
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemiaSébastien Anguille, Ann L Van de Velde, Evelien L Smits, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2024
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)María Paniagua-García, Jose M Bravo-Ferrer, Salvador Pérez-Galera, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countriesXiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open|July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocolEmily Bongard, Alike W van der Velden, Johanna Cook, et al.
Eclinicalmedicine|March 10, 2023
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, et al.
CMAJ Open|December 22, 2021
The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional surveyGreg J German, Charles Frenette, Jean-Alexandre Caissy, et al.
Frontiers in Immunology|January 9, 2023
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsAngelina Konnova, Fien H R De Winter, Akshita Gupta, et al.
Pageof 49